Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lo2 Phase II: A Comparison of Live Birth Rates Between Embryos Cultured in 2% vs. 5% After Day 3 of Embryo Culture

NCT03147872 is registered in ClinicalTrials.gov with Reproductive Medicine Associates of New Jersey as lead sponsor.

NCT NCT03147872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03147872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lo2 Phase II: A Comparison of Live Birth Rates Between Embryos Cultured in 2% vs. 5% After Day 3 of Embryo Culture
Lead sponsor
Reproductive Medicine Associates of New Jersey
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
January 31, 2021
Enrollment
280 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility